Type 1 and type 2 cytokines: From basic science to fungal infections

Medical Mycology, Supplement

Volumn 36, Issue 1, 1998, Pages 109-118

  Murphy, J W ^a   Bistoni, F ^b   Deepe, G S ^b   Blackstock, R A ^b   Buchanan, K ^b   Ashman, R B ^b   Romani, L ^b   Mencacci, A ^b   Cenci, E ^b   Fe D'Ostiani C ^b   Del Sero, G ^b   Calich, V L G ^b   Kashino, S S ^b  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b NONE

Author keywords

Candida albicans; CMI; Cryptococcus neoformans; Cytokines; H. capsulatum; Paracoccidioides brasiliensis

Indexed keywords

ANTIFUNGAL AGENT; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; HELPER CELL; HISTOPLASMA CAPSULATUM; IMMUNE RESPONSE; MOUSE; MYCOSIS; NONHUMAN; PARACOCCIDIOIDES BRASILIENSIS; REVIEW; STRAIN DIFFERENCE;

ANIMALS; CYTOKINES; FUNGI; HUMANS; MICE; MYCOSES; TH1 CELLS; TH2 CELLS;

EID: 0003288311     PISSN: 09668454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Janeway CA, Travers P. Immunobiology. The Immune System in Health and Disease. (2nd, ed.) New York: Garland Publishing Inc. 1996.
2. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251-76.
3. Reiner SL, Zheng S, Corry DB, Locksley RM. Constructing polycompetitor cDNAs for quantitative PCR. J Immunol Meth 1993; 165: 37-46.
4. Wu-Hsieh BA, Howard DH, Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect Immun 1987; 55: 1014-26.
5. Zhou P, Sieve MC, Bennett J et al. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-γ. J Immunol 1995; 155: 785-95.
6. Allendoerfer R, Boivin GP, Deepe GS. Modulation of immune responses in murine pulmonary histoplsmosis. J Infect Dis 1997; 175: 905-14.
7. Dinarello CA, Cannon JG, Wolff SM. et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-50.
8. Seder RA, Kelsall BL, Jankovic D. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune diseases. J Immunol 1996; 157: 2745-8.
9. Murphy JW. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response. Infect Immun 1993; 61: 4750-9.
10. Buchanan KL, Murphy JW. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response. Infect Immun 1993; 61: 2854-65.
11. Crowle AJ. Delayed hypersensitivity in the mouse. Adv Immunol 1975, 20: 197-264.
12. Pearce EJ, Caspar P, Grzych J, Lewis FA, Sher A. Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 1991; 173: 159-66.
13. Romani L, Mocci S, Bietta C, Lanfaloni L, Puccetti P, Bistom F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 1991; 59: 4647-54.
14. Romani L, Mencacci A, Grohmann U. et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19-25.
15. Romani L, Mencacci A, Cenci E. et al. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 1993; 150: 925-31.
16. Mencacci A, Cenci E, Spaccapelo R. et al. Rationale for cytokine and anti-cytokine therapy of Candida albicans infection. J Mycol Med 1995; 5: 25-30.
17. Cenci E, Mencacci A, Spaccapelo R. et al. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J Infect Dis 1995; 171: 1279-88.
18. Bistoni F, Cenci E, Mencacci A. et al Mucosal and systemic T helper cell function after intragastric colonization of adult mice with Candida albicans. J Infect Dis 1993; 168: 1449-57.
19. Ashman RB, Bolitho EM, Fulurija A. Cytokine mRNA in brain tissue from mice that show strain-dependent differences in the severity of lesions induced by systemic infection with Candida albicans yeast. J Infect Dis 1995; 172: 823-30.
20. Marquis G, Montplaisir S, Pelletier M. et al. Genetics of resistance to infection with Candida albicans in mice. Br J Exp Pathol 1988; 69: 651-60.
21. Salvin SB, Neta R. Resistance and susceptibility to infection in inbred murine strains. I. Variations in the response to thymic hormones in mice infected with Candida albicans. Cell Immunol 1983; 75: 160-72.
22. Ashman RB, Bolitho EM, Papadimitriou JM. Patterns of resistance to Candida albicans in inbred mouse strains. Immunol Cell Biol 1993; 71: 221-5.
23. Ashman RB, Papadimitriou JM. Murine candidiasis. Pathogenesis and host responses in genetically distinct inbred mice. Immunol Cell Biol 1987; 65: 163-71.
24. Ashman RB, Papadimitnou JM. Genetic regulation of pathogenesis and host responses in fungal infection. In: Kurstak E, Marquis G. eds Immunology of Fungal Infection. New York: Marcel Dekker 1989; 347-371.
25. Ashman RB, Papadimitriou JM. Genetic resistance to Candida albicans infection is conferred by cells derived from the bone marrow. J Infect Dis 1992; 166: 947-8.
26. Ashman RB, Fulurija A, Papadimitriou JM. Evidence that two independent host genes influence the severity of tissue damage and susceptibility to acute pyelonephritis in murine systemic candidiasis. Microb Pathog 1997; 22.
27. Decker T, Lohmann-Matthes ML, Baccarini M. Heterogeneous activity of immature and mature cells of the murine monocyte-macrophage lineage derived from different anatomical districts against yeast-phase Candida albicans. Infect Immun 1986; 54: 477-86.
28. Fulurija A, Ashman RB, Papadimitriou JM. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 1996; 142.
29. Ashman RB, Fulurija A, Papadimitriou JM. Strain-dependent differences in host response to Candida albicans infection in mice are related to organ susceptibility and infectious load. Infect Immun 1996; 64: 1866-9.
30. Mencacci A, Spaccapelo R, Del Sero G. et al. CD4+ T-helper-cell responses in mice with low-level Candida albicans infection. Infect Immun 1996; 64: 4907-14.
31. Screpanti I, Romani L, Musiani P. et al. Lymphoproliferative disorder and imbalances T-helper response in C/EBPb-deficient mice. Embo J 1995; 14: 1932-41.
32. Romani L, Mencacci A, Cenci E. et al. Impaired neutrophil response and CD4+ T helper cell development in interleukin-6-deficient mice infected with Candida albicans. J Exp Med 1996; 183: 1345-55.
33. Spaccapelo R, Romani L, Tonnetti L. et al. TGF-β is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J Immunol 1995; 155: 1349-60.
34. Romani L, Puccetti P, Bistoni F. Biological role of Th cell subsets in candidiasis. Chem Immunol 1996; 63: 115-37.
35. Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3: 237-40.
36. Cenci E, Mencacci A, Del Sero G, Bistoni F, Romani L. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. J Infect Dis 1997; in press.
37. Restrepo A. Immune responses to Parucoccidioides brasiliensis. In McGinnis MR, ed. Current Topics in Medical Mycology. New York: Springer Verlag 1988239-275, Vol. 2.
38. Calich VLG, Singer-Vermes LM, Siqueira AM, Burger E. Susceptibility and resistance of inbred mice to Paracoccidioides brasiliensis. Br J Exp Pathol 1985; 66: 585-94.
39. Calich VLG, Singer-Vermes LM, Russo M, Vaz CAC, Burger. Immunogenetics in paracoccidioidomycosis. In: Franco M, Lacaz CS, Restrepo AM, Del Negro G, eds Paracoccidioidomycosis. Boca Raton, FL. CRC Press 1994 151-178.
40. Murphy JW, Wu-Hsieh B, Singer-Vermes LM. et al. Cytokines in the host response to mycotic agents. J Med Vet Mycol 1994; 32: 203-10.
41. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Ann Rev Immunol 1995; 13: 151-78.
42. Seder MD, Paul WE. Acquisition of lymphokine producing phenotype by CD4+ T cells. Ann Rev Immunol 1994; 13: 251-76.
43. Arruda C, Singer-Vermes LM, Vaz CAC, Burger E, Calich VLG. Protection and exacerbation of murine paracoccidioidomycosis by previous sc inoculation of yeast cells. XII Congress of the International Society for Human and Animal Mycology. Adelaide, Australia 1992; Abstr. PO3. 17.
44. Kashino SS, Fazioli RA, Bruneri L, Burger E, Singer-Vermes LM, Calich VLG. Cytokine production (IL-2, IFN-γ, IL-4, and IL-10) in the protection and exacerbation models of murine experimental paracoccidioidomycosis. International Meeting on Cytokines. Angra dos Reis, RJ 1996; Abstr. 01.55.
45. Cano LE, Singer-Vermes LM, Vaz CAC, Russo M, Calich VLG. Pulmonary paracoccidioidomycosis in resistant and susceptible mice: relationship among progression of infection, bronchoalveolar cell activation, cellular immune responses and specific isotype patterns. Infect Immun 1995; 63: 1777-83.